Companies / Enliven Therapeutics, Inc. / Transactions
Back to Enliven Therapeutics, Inc.

Enliven Therapeutics, Inc.

All insider transactions

36 transactions

Date ↓MoveSecurityInsiderΔ sharesPriceValueHeld afterImpact
Jun 22, 2026Sell
ⓘ
Common StockORBIMED ADVISORS LLC
10% owner
-46,776$45.00$2.10M6,555,102medium
Jun 22, 2026Sell
ⓘ
Common StockORBIMED ADVISORS LLC
10% owner
-787,024$45.38$35.72M6,601,878high
Jun 22, 2026Sell
ⓘ
Common StockORBIMED ADVISORS LLC
10% owner
-1,477$45.00$66.5K219,405low
Jun 22, 2026Sell
ⓘ
Common StockORBIMED ADVISORS LLC
10% owner
-24,846$45.38$1.13M220,882medium
Jun 15, 2026Sell
ⓘ
Common StockORBIMED ADVISORS LLC
10% owner
-272,322$45.02$12.26M7,388,902high
Jun 15, 2026Sell
ⓘ
Common StockORBIMED ADVISORS LLC
10% owner
-9,086$45.02$409.1K245,728medium
Mar 25, 2026Sell
ⓘ
Common StockCollins Helen Louise
Executive
-40,000$35.10$1.40M25,000medium
Mar 25, 2026Other
Option exercise ⓘ
Common StockCollins Helen Louise
Executive
+40,000$2.48$99.2K65,000low
Mar 17, 2026SellCommon StockCollins Helen Louise
Executive
-5,000$27.76$138.8K25,000medium
Mar 17, 2026Other
Option exercise
Common StockCollins Helen Louise
Executive
+5,000$2.48$12.4K30,000low
Mar 10, 2026SellCommon StockCollins Helen Louise
Executive
-10,129$30.19$305.8K25,000medium
Mar 10, 2026Other
Option exercise
Common StockCollins Helen Louise
Executive
+10,129$2.48$25.1K35,129low
Mar 9, 2026SellCommon StockCollins Helen Louise
Executive
-29,871$30.02$896.8K25,000medium
Mar 9, 2026Other
Option exercise
Common StockCollins Helen Louise
Executive
+29,871$2.48$74.1K54,871low
Mar 6, 2026SellCommon StockHohl Benjamin
Executive
-10,000$29.58$295.8K51,000medium
Feb 17, 2026SellCommon StockCollins Helen Louise
Executive
-45,000$26.17$1.18M25,000medium
Feb 17, 2026Other
Option exercise
Common StockCollins Helen Louise
Executive
+45,000$2.48$111.6K70,000low
Feb 17, 2026SellCommon StockHeyman Richard A.
Director
-1,230$26.18$32.2K22,647low
Feb 12, 2026Other
Grant / award
Common StockCollins Helen Louise
Executive
+25,000$0.00$025,000low
Feb 12, 2026Other
Grant / award
Common StockPatel Anish
Executive
+20,000$0.00$020,000low
Feb 12, 2026Other
Grant / award
Common StockLyssikatos Joseph P
Executive
+18,750$0.00$018,750low
Feb 12, 2026Other
Grant / award
Common StockHohl Benjamin
Executive
+25,000$0.00$061,000low
Feb 6, 2026SellCommon StockLyssikatos Joseph P
Executive
-5,000$29.04$145.2K740,188medium
Jan 20, 2026SellCommon StockLyssikatos Joseph P
Executive
-14,509$26.90$390.3K745,188medium
Jan 20, 2026SellCommon StockLyssikatos Joseph P
Executive
-5,491$26.37$144.8K759,697medium
Jan 20, 2026SellCommon StockHeyman Richard A.
Director
-718$26.96$19.4K23,877low
Jan 20, 2026SellCommon StockHeyman Richard A.
Director
-512$26.46$13.5K24,595low
Jan 9, 2026SellCommon StockPatel Anish
Executive
-243$28.50$6.9K215,011low
Jan 9, 2026SellCommon StockPatel Anish
Executive
-48,057$27.98$1.34M215,254medium
Jan 9, 2026SellCommon StockLyssikatos Joseph P
Executive
-50,000$29.13$1.46M765,188medium
Jan 9, 2026SellCommon StockLyssikatos Joseph P
Executive
-41,198$24.90$1.03M815,188medium
Jan 9, 2026SellCommon StockHeyman Richard A.
Director
-4,285$25.00$107.1K25,107medium
Jan 8, 2026SellCommon StockLyssikatos Joseph P
Executive
-33,802$24.92$842.5K856,386medium
Jan 8, 2026SellCommon StockLyssikatos Joseph P
Executive
-7,500$20.13$151.0K890,188medium
Jan 8, 2026SellCommon StockHeyman Richard A.
Director
-8,015$25.04$200.7K29,392medium
Jan 8, 2026SellCommon StockHeyman Richard A.
Director
-1,620$25.00$40.5K25,545low
← PrevPage 1 of 1Next →